According to Franklin Covey's latest financial reports the company's current earnings (TTM) are $23.71 M. In 2023 the company made an earning of $25.08 M an increase over its 2022 earnings that were of $23.01 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | $23.71 M | -5.45% |
2023 | $25.08 M | 8.99% |
2022 | $23.01 M | 93.34% |
2021 | $11.9 M | 1311.98% |
2020 | $0.84 M | -22.59% |
2019 | $1.08 M | -135.86% |
2018 | -$3.04 M | -65.37% |
2017 | -$8.77 M | -285.18% |
2016 | $4.73 M | -69.79% |
2015 | $15.67 M | -28.22% |
2014 | $21.84 M | 23.73% |
2013 | $17.65 M | 14.88% |
2012 | $15.36 M | 75.05% |
2011 | $8.77 M | 172.02% |
2010 | $3.22 M | -126.88% |
2009 | -$12.01 M | -247.04% |
2008 | $8.16 M | -51.08% |
2007 | $16.69 M | 28.82% |
2006 | $12.95 M | 22.7% |
2005 | $10.56 M | -346.35% |
2004 | -$4.29 M | -89.93% |
2003 | -$42.59 M | -54.02% |
2002 | -$92.61 M | 86.14% |
2001 | -$49.76 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Spero Therapeutics SPRO | $25.4 M | 7.12% | ๐บ๐ธ USA |
Universal Technical Institute UTI | $27.46 M | 15.80% | ๐บ๐ธ USA |